Computer-Aided Diagnosis of ER-positive, HER2-Negative Breast Cancer on Dynamic Contrast-Enhanced MRI: Associations With Oncotype DX Recurrence Scores
Clinical Breast Cancer · 2025
DOI: 10.1016/j.clbc.2025.04.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Jin Joo Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Repu…. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging, Neoplasm Recurrence, Local, Diagnosis, Computer-Assisted. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Pusan National University Hospital, Texas Biomedical Research Institute, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México.
Abstract (Originalsprache)
PURPOSE: To investigate whether kinetic features derived from computer-aided diagnosis (CAD) and their heterogeneity at dynamic contrast-enhanced MRI are associated with the risk of breast cancer recurrence in patients with ER-positive, HER2-negative invasive breast cancer who have undergone the Oncotype DX assay. METHODS: We retrospectively evaluated 227 women (mean age, 53 years) with newly diagnosed ER-positive, HER2-negative breast cancer who had undergone preoperative MRI and the Oncotype DX assay between 2018 and 2022. The enhancement kinetic parameters and their kinetic heterogeneity for each breast cancer were assessed using a CAD system and correlated with the Oncotype DX RS. RESULTS: Of the 227 cancers, 61 (26.9%) had low (< 11), 141 (62.1%) had intermediate (11-25), and 25 (11.0%) had high (≥ 26) RS. The high-risk group (RS ≥ 26) had significantly higher mean Angio volume and kinetic heterogeneity on CAD compared to the nonhigh-risk group (RS < 26) (2.52 cm3 vs. 1.42 cm3, P = .023; .78 vs. .62, P = .025). Multivariate regression showed that higher kinetic heterogeneity (odds ratio [OR] 12.57, P = .024), high histologic grade (grade 3; OR 21.30, P< .001), progesterone receptor negativity (OR 21.30, P = .005) and higher Ki-67 (≥ 25%; OR 21.30, P= .006) were associated with a high-risk of recurrence. CONCLUSION: Higher kinetic heterogeneity on CAD was associated with an increased risk of recurrence in patients with ER-positive, HER2-negative breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea.
- Department of Radiology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea. Electronic address: youdosa@naver.com.
Förderung
- Pusan National University Hospital
- Texas Biomedical Research Institute
- Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México
Zitieren
APA
Kim, J. J., Kim, J. Y., Hwangbo, L., & Lee, H. (2025). Computer-Aided Diagnosis of ER-positive, HER2-Negative Breast Cancer on Dynamic Contrast-Enhanced MRI: Associations With Oncotype DX Recurrence Scores. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.04.014
Vancouver
Kim JJ, Kim JY, Hwangbo L, Lee H. Computer-Aided Diagnosis of ER-positive, HER2-Negative Breast Cancer on Dynamic Contrast-Enhanced MRI: Associations With Oncotype DX Recurrence Scores. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2025.04.014
BibTeX
@article{Kim2025,
author = {Kim, Jin Joo and Kim, Jin You and Hwangbo, Lee and Lee, Hojun},
title = {Computer-Aided Diagnosis of ER-positive, HER2-Negative Breast Cancer on Dynamic Contrast-Enhanced MRI: Associations With Oncotype DX Recurrence Scores},
journal = {Clinical Breast Cancer},
year = {2025},
doi = {10.1016/j.clbc.2025.04.014}
}
EUVIMED